WO1996025910A1 - Water-soluble pressure-sensitive mucoadhesive - Google Patents

Water-soluble pressure-sensitive mucoadhesive Download PDF

Info

Publication number
WO1996025910A1
WO1996025910A1 PCT/US1996/002666 US9602666W WO9625910A1 WO 1996025910 A1 WO1996025910 A1 WO 1996025910A1 US 9602666 W US9602666 W US 9602666W WO 9625910 A1 WO9625910 A1 WO 9625910A1
Authority
WO
WIPO (PCT)
Prior art keywords
water
soluble
sensitive adhesive
soluble pressure
polymer
Prior art date
Application number
PCT/US1996/002666
Other languages
French (fr)
Inventor
James E. Biegajski
Subbu S. Venkatraman
William Abraham
Original Assignee
Cygnus, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cygnus, Inc. filed Critical Cygnus, Inc.
Priority to AU52999/96A priority Critical patent/AU5299996A/en
Publication of WO1996025910A1 publication Critical patent/WO1996025910A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L1/00Compositions of cellulose, modified cellulose or cellulose derivatives
    • C08L1/08Cellulose derivatives
    • C08L1/26Cellulose ethers
    • C08L1/28Alkyl ethers
    • C08L1/284Alkyl ethers with hydroxylated hydrocarbon radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09JADHESIVES; NON-MECHANICAL ASPECTS OF ADHESIVE PROCESSES IN GENERAL; ADHESIVE PROCESSES NOT PROVIDED FOR ELSEWHERE; USE OF MATERIALS AS ADHESIVES
    • C09J101/00Adhesives based on cellulose, modified cellulose, or cellulose derivatives
    • C09J101/08Cellulose derivatives
    • C09J101/26Cellulose ethers
    • C09J101/28Alkyl ethers
    • C09J101/284Alkyl ethers with hydroxylated hydrocarbon radicals
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L2666/00Composition of polymers characterized by a further compound in the blend, being organic macromolecular compounds, natural resins, waxes or and bituminous materials, non-macromolecular organic substances, inorganic substances or characterized by their function in the composition
    • C08L2666/02Organic macromolecular compounds, natural resins, waxes or and bituminous materials
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L39/00Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen; Compositions of derivatives of such polymers
    • C08L39/04Homopolymers or copolymers of monomers containing heterocyclic rings having nitrogen as ring member
    • C08L39/06Homopolymers or copolymers of N-vinyl-pyrrolidones

Definitions

  • This invention relates to mucoadhesives, and particularly to compositions that adhere both to mucosal surfaces and to a variety of materials that may constitute a part of a device or prosthesis to be held in a body cavity that has a mucosal lining.
  • U.S. Patent No. 4,713,243 describes an extruded film for use in controlled release of medicaments, including a water-soluble or swellable polymer matrix capable of adhering to a wet mucous surface, made up of 40 - 95 % hydroxy propyl cellulose, 5 - 60 % poly(ethylene oxide), optionally up to 10 % of a water-insoluble polymer (ethyl cellulose, propyl cellulose, polyethylene or polypropylene) and 2 - 10 % of a plasticizer introduced to facilitate processing, and containing the medicament.
  • a water-insoluble polymer ethyl cellulose, propyl cellulose, polyethylene or polypropylene
  • plasticizer introduced to facilitate processing, and containing the medicament.
  • Patent No. 4,948,580 describes a bioadhesive composition for delivery of anti-bacterials, including a copolymer of ("PVME/MA”), and gelatin, dispersed in an ointment base.
  • Adhesives for affixing dental prostheses in the mouth are conventionally in the form of pastes or creams. These are messy and inconvenient to use, and generally adhere poorly or not at all after extended periods.
  • U.S. Patent No. 4,529,748 describes a dental prosthesis adhesive in powder form, in which the particles are made from carboxy methyl cellulose, poly(ethylene oxide), poly(acrylic acid), and karaya gum. Some portion of the particles are coated with a cellulose or acrylate polymer film that dissolves slowly in saliva.
  • water-soluble pressure-sensitive mucoadhesives that additionally adhere to a variety of materials, such as polymers, that can be used in construction of devices for emplacement on a mucosal surface or within a body cavity that has a mucosal lining.
  • the adhesives require no moistening prior to contact with the mucosal or the polymer surface.
  • Water-soluble pressure-sensitive mucoadhesive films according to the invention can be used, for example, to affix a dental plate within the mouth.
  • water-soluble pressure sensitive films according to the invention can constitute the adhesive layer of a laminated mucoadhesive device for emplacement in a mucosa-lined body cavity and delivery of one or more active substances into the body cavity, in which additional layers or layers, also soluble in the fluids bathing the surface of the body cavity, contain the active substance or substance to be delivered.
  • the invention features a layered composite mucoadhesive device for delivery of an active substance into the oral cavity, having an active-containing layer that includes the active substance dispersed or dissolved in a water soluble polymer, and a water soluble adhesive layer.
  • the active-containing water soluble polymer layer is a hydrophobic material that will not dissolve in cold water (below about 40°C) and has little or no tendency to hydrate with water.
  • the material may further be hot water dispersible and may have non-tacky surface properties upon moistening.
  • suitable GRAS-certified materials include but are not limited to monoglycerides, triglycerides, waxes such as paraffin, fatty acids, fatty alcohols and mixtures thereof.
  • the rate of release of the active substance within the oral cavity depends to at least some extent upon the rate of dissolution or dispersion of the polymer of the active layer in situ, which in turn varies substantially according to the molecular weight of the principal polymer component: a given polymer type dissolves or disperses more slowly at higher molecular weights than at lower molecular weights.
  • the active-containing layer includes a polymer such as hydroxypropyl cellulose, and may additionally include a plasticizer such as glycerin.
  • hydroxypropyl cellulose HPC Klucel LF
  • HPC Klucel LF hydroxypropyl cellulose having a molecular weight of 80,000, with glycerin as a plasticizer, is useful.
  • any of a variety of active substances may be delivered using devices constructed according to the invention.
  • Such active substances are well known to those of skill in the art to which this invention pertains.
  • substance such as benzocaine, lidocaine, dyclonine and the like, which are available over the counter or in syrup or tablet form, may be used.
  • Suitable odorants and flavorants include, for example, mint odorants and fruit flavorants such as citrus flavorants, cherry flavorants, and the like. Reference is made to G. Reineccius, ed. Source Book of Flavors, Chapman & Hall.
  • the adhesive preferably is made from materials generally regarded as safe (“GRAS-certified”), or national formulary (“NF-certified”), and therefore safe for oral use or for ingestion.
  • GRAS-certified safe
  • NF-certified national formulary
  • the pressure-sensitive adhesives of the invention are fully water-soluble, and are thus fully soluble in secretions present in mucous-lined body cavities. Consequently, the adhesive eventually dissolves completely within the body cavity in which they are placed, and is flushed away with the fluid secretions of the cavity or, in the case of use in the oral cavity, passes on to the alimentary canal.
  • the invention features a water-soluble pressure-sensitive adhesive including a water-soluble polymer that is made tacky (that is, it is rendered pressure-sensitive) at room temperature by addition of a water-soluble plasticizer that is miscible with the polymer.
  • Suitable polymers are characterized as being solid at room temperature (that is, as having a glass transition temperature T(g), or melting point T(m), higher than about 25°C, and more preferably higher than about 30°C, and lower than about 120°C, and more preferably lower than about 100°C); and having a hydrophilicity as measured by water uptake greater than about 25 %.
  • Suitable plasticizers are characterized as being liquid at room temperature and having a boiling point higher than about 80°C.
  • Suitable polymers include polysaccharides such as for example cellulose- type materials and natural gums, polypeptides, and water-soluble synthetic polymers.
  • suitable polymers which are GRAS certified include poly(vinyl pyrrolidone) ("PVP"), poly(vinyl alcohol) (“PVA”), hydroxy propyl cellulose (“HPC”), polyethylene oxide) (“PEO”), poly(acrylic acid) (“PAA”), polyacrylates such as Carbopol 934 (B.F. Goodrich), starch and starch derivatives, polysaccharides, sodium carboxymethyl cellulose
  • Suitable plasticizers include, for example and particularly for oral-mucosal contact and other use in the oral cavity, glycerin, sorbitol, any of the glycols, polysorbate 80, triethyl citrate, acetyl triethyl citrate, and tributyl citrate.
  • a water-soluble pressure-sensitive adhesive according to the invention includes PVP (about 95 - 40 weight %) and, optionally, HPC (up to about 50 weight %) as a polymer; and glycerin as a plasticizer (about 5 - 35 weight %).
  • any balance (up to about 30 weight %) can be made up by water.
  • such compositions adhere instantaneously (within less than five seconds) to oral mucosal surfaces and to oral cavity prostheses or other devices of the poly(methyl methacrylate) (“PMMA”) type, as well as to human skin.
  • PMMA poly(methyl methacrylate)
  • a water-soluble pressure-sensitive adhesive includes as a polymer HPC (about 0 - 50 weight %) and, optionally, (up to about 50 weight %) one or more of PVP, PVA, PEO, starch, polysucrose or other polysaccharide, xanthan gum, or karaya gum; and glycerin as a plasticizer (about 1 1 - 60 weight % and, preferably about 30 - 50 weight % for PVP- or HPC-containing adhesive compositions).
  • the HPC preferably has a molecular weight between about 60 k and about 1 ,000 k, and more preferably between about 100 k and about 300 k.
  • the invention features a water-soluble pressure-sensitive adhesive film made up of a water-soluble polymer that is made tacky (that is, it is rendered pressure-sensitive) at room temperature by addition of a water-soluble plasticizer that is miscible with the polymer.
  • the thickness of the film is in the range of about 5 - 20 mils, and is shaped to fit and to conform generally to a mucosal surface- contacting portion of a dental prosthesis such as a dental plate.
  • Preferred water- soluble pressure-sensitive adhesive films according to the invention are very flexible, and are therefore capable of conforming to and adhering to contoured surfaces such as the gum or the roof of the mouth.
  • Such a film can be used as a denture adhesive, that can adhere to oral mucosal surfaces and to dental prosthesis for an extended period, typically of more than about 5 hours.
  • the film can be used as part of a system for delivery of substances through the oral mucosa (as a buccal transmucosal patch), or for delivery of substances into the oral cavity itself.
  • the invention features a laminated mucoadhesive device for emplacement on a mucosal surface, such as on a surface within a body cavity that has a mucosal lining, which device has a first layer made up of a water-soluble pressure-sensitive adhesive as described herein and a second water- soluble layer containing the active substance. As the active substance-containing layer dissolves or otherwise disperses within the fluids bathing the surface of the body cavity, the active substance is released into and is carried by the fluids.
  • the laminated device includes two or more water soluble active substance-containing layers.
  • Each of the layers may contain a different active substance or combination of active substances, for example; or they may contain the same active substance but in differing amounts.
  • the different active substance-containing layers may dissolve or disperse at different rates in the fluids of the body cavity, so that the rate of release of the active substance or active substances may vary over time.
  • the active substance includes a flavorant or deodorant or reordorant and is useful in the body cavity as a deodorant or odor masking agent, for example as a breath freshener in the oral cavity; or it includes an antibacterial or antifungal agent, useful in the body cavity to treat enfection or to prevent formation of odor; or it includes an anaesthetic or analgesis, useful in the body cavity to treat pain.
  • a solution of poly( vinyl pyrrolidone) (“PVP”: Kollidon®, obtained from BASF) and glycerin was first prepared in isopropyl alcohol (“IPA”), in the following proportion by weight: 15 parts PVP, 6 parts glycerin, and 79 parts IPA.
  • IPA isopropyl alcohol
  • the solution was coated on a polyester release liner and allowed to dry at room temperature for 15 hours to permit evaporation of the IPA.
  • the resulting dry film is both pressure-sensitive and water-soluble.
  • Measurements of tack were made using a TA.XT2 Texture Analyzer (Texture Technologies Corp.) together with an XT.RA Dimension software package (Stable Micro Systems, Ltd.), as follows. A sample of the film on a release liner is mounted upon a block, and a probe is moved at a fixed speed against the adhesive surface of the film, distorting the film to a fixed penetration depth, where the probe is permitted to dwell for a fixed time. The probe is then withdrawn from the film, at a fixed speed, and the peak force required to detach the probe from the film surface is measured as a measure of tack.
  • Measured tack of samples of a PVP-glycerin film prepared as described above and having 5 mils thickness was 1820 g/cm 2 , using a probe diameter of 0.80 cm, a penetration depth of 0J mm, a penetration rate of 1.0 mm/sec, a dwell time of 10 sec, and a withdrawal rate of 5.0 mm/sec.
  • Typical tack values for adhesives used in transdermal devices are about 1000 - 2000 g/cm .
  • Measurements of water solubility were made by submersion of a sample of the film in water at 21°C, stirring the water, and determining the time required for apparent complete dissolution of the film.
  • the total measured dissolution time of samples of a PVP-glycerin film prepared as described above and having 5 mils thickness was about 10 minutes.
  • HPC Hydroxy propyl cellulose
  • PVP glycerin
  • the resulting film was flexible, translucent and tacky at room temperature.
  • a water-soluble pressure-sensitive adhesive film made as described above can be die-cut in a shape that conforms to that portion of the dental prosthesis that closely fits the mucosal surface of the mouth, such as the part of the dental plate that fits against the palate.
  • the shaped film pieces can be packaged dry. For use, the dry film is pressed onto the appropriate surface of the dental prosthesis so that it adheres. Then the dental prosthesis with the adhesive affixed is inserted into the correct position in the mouth and pressed against the mucosal surface until adhesion is achieved.
  • a dissolvable mucoadhesive device capable of releasing a flavor into the oral cavity was constructed as follows: A solution was made up by co-dissolving 15.4 grams of polyvinyl pyrrolidone PVP (K90) and 6.0 grams of glycerin in 80 grams of isopropanol (IPA). The resulting solution was coated at a thickness of 30 mils onto a polyester release liner and allowed to dry for 15 hours at room temperature. The resulting dry film was tacky at room temperature and had a final thickness of about 5 mils.
  • a second solution containing 43 grams of IPA, 42 grams of water, 15 grams of HPC EF, 2.5 grams of peppermint oil and 3.0 grams of NutrasweetO brand sweetener containing aspartame was prepared by mixing all the components until fully dissolved. The solution was then coated at a thickness of 50 mils onto a polyester release liner. The film was allowed to dry at room temperature for 15 hours to a final thickness of about 5 mils.
  • the two dry films were laminated together. Discs having a diameter of about 1.2 cm were cut from the laminate. The discs were tested in vivo by adhering a single disc to the upper palate of three volunteers. The discs adhered well to the mucosal surface and upon hydration with saliva immediately began releasing peppermint oil and aspartame as noticed by taste. The total time of dissolution in the mouth was about 10 minutes, during which time a pleasant, refreshing mint flavor was perceived.
  • adhesive layer compositions having various selected proportions of PVP, HPC, and Glycerol were tested both for peak tack and for time required to complete dissolution, in order to determine both the relative contribution each of these components makes to the tack and dissolution time characteristics of the adhesive, and to determine the ranges within which the proportions of these components preferable are provided, to provide adhesives having good tack and dissolution time characteristics.
  • the adhesive layers were constructed by blending HPC, PVP and Glycerin in the selected proportion, and pressing the resulting mixture in a heated Carver laboratory press at 200 F. to a thickness about 35 mils.
  • Peak tack was tested on adhesive disks having 10 mils thickness, using a TA.XT2 Texture Analyzer, with a Plexiglas probe having a diameter 8mm, advanced to the surface at 1 mm/sec to a force threshold of 20 grams, then advanced at a penetration rate of 0J mm/sec to a penetration depth of 0.5 mm, held for 10 seconds at a contact force of 125 grams, and then withdrawn at 1 mm/sec. Time to complete dissolution was measured by affixing an adhesive disc to the inner wall of a vial containing 100 ml nanopure water at room temperature and stirring the water at 250 rpm.
  • a medication-containing mucoadhesive laminated disc according to the invention can be made by forming and then laminating an adhesive film and an active substance-containing polymer film generally as follows.
  • a water-soluble adhesive layer can be formed from an adhesive polymer film, according to the following general protocol. First, the polymer (or polymers) and the plasticizer are thoroughly mixed, using where necessary a suitable solvent such as ethyl alcohol. Where a solvent is used, the resulting mixture is then coated on a release liner, and the solvent is allowed to evaporate to produce a dry film. Dry film samples are then collected and pressed to the desired final film thickness. Where no solvent is used, the mixture can be pressed to a film of the desired thickness.
  • a suitable solvent such as ethyl alcohol
  • the active substance-containing layer First, the polymers and one or more desired active agents and one or more desired flavorants are dissolved, for example by stirring, in an appropriate solvent. Then the resulting thickened solution is formed into a thin (wet) film, for example by casting onto a release liner, and then the solvent is permitted to evaporate to a dry film. Then the dry film is pressed to a desired thickness and is affixed, for example by pressing, onto an adhesive layer prepared as described above.
  • HPC Hydroxypropyl cellulose
  • HPC can be a particularly suitable polymer for construction of the active-containing layer.
  • HPC dissolves completely in aqueous fluids such as the fluids of the oral cavity, and within a selected range of molecular weights, HPC dissolves (or disperses) in the oral cavity sufficiently slowly to provide substantially continuous delivery of the active substance over an extended period.
  • HPC is flexible, so that it conforms well to irregular curved surfaces of the oral cavity; HPC is not tacky when moistened, and has a pleasant texture in the mouth. It is thus comfortable and unobtrusive for the user.
  • HPC blends well with a variety of active substances.
  • Glycerol which may be added as a plasticizer in the active-containing layer, may additionally (or alternatively) act to inhibit crystallization of some active substances that might otherwise occur at the loading concentrations employed (for example, menthol).
  • Laminated devices are then cut from the laminated film by, for example, die-cutting, to the desired size and shape. Typically, circular or oval shapes may be preferred.
  • the devices can be stored on a release liner affixed to the adhesive surface, and removed from the liner as needed by the user.
  • a device having a single active substance-containing layer containing a pain-relieving agent such as dyclonine A in amounts sufficient to provide sore throat pain relief initially can have the undesired effect of unpleasantly numbing other tissues in the oral cavity that are adjacent the device while in place, such as the tongue.
  • a pain-relieving agent such as dyclonine A
  • a preferred device for two-phase delivery of an active substance for relief of sore throat has two active-containing layers, a first layer adjacent the adhesive layer, from which the active is released more slowly over time, and a second layer adjacent the first active-containing layer, from which the active is released more rapidly, over a shorter initial time following placement within the body cavity.
  • Such a configuration provides for an initial burst of the pair-relieving active agent at a suitably high rate to satisfactorily reduce sore throat pain, followed by a sustained release of the active agent at a lower rate suitably high to maintain the effect of pain reduction but not so high as to cause unpleasant numbness in the oral cavity.
  • this invention also provides a method of delivery an active substance to a subject such as a human patient by contacting a device as described herein with a suitable surface of the subject.
  • Suitable surfaces include, but are not limited to a mucosa-lined body cavity such as the oral cavity, the cornea stratum or the skin of the subject.
  • the two-phase release profile can be achieved either by having the two active-containing layers made from the same polymer (or from similar polymers dissolving or dispersing at about the same rate) but having the active agent present in the lower, sustained release layer at a lower concentration than in the upper, initial burst, layer.
  • the upper layer can dissolve or disperse more quickly in the oral milieu.
  • the device is about 0.5 inches in diameter
  • the layers are made from the same HPC polymer
  • the initial release layer can be 5-10 mils thick, and contain 0.25-0.6 milligrams of dyclonine
  • the sustained release layer can be 20-25 mils thick, and contain
  • Such a configuration can provide satisfactory throat pain relief within about 1—20 minutes' time, followed by a sustained relief over a time greater than an hour thereafter, while reducing the numbing effect associated with delivery at a constant higher rate.
  • the water-soluble pressure-sensitive adhesives according to the invention can be used to affix transdermal devices to human skin. Because the materials in the adhesive are GRAS certified, they can result in an adhesive product having very low skin irritation and reaction.
  • the water-soluble pressure-sensitive adhesives of the invention can act as a reservoir for diffusional delivery of a substance into the mucosa-lined body cavity (such as the oral cavity or gastrointestinal tract, or the vaginal cavity), or for delivery of a substance transmucosally through the area of adhesive contact.
  • the adhesive is provided in film form, and is loaded with a suitable quantity of the substance to be delivered.
  • one surface of the adhesive film makes adhesive contact with the mucosal surface; preferably the other surface of the adhesive film is covered with a substance-occlusive backing layer made of a material that is poorly soluble in water or in the fluid secretions of the body cavity in which the film is used.
  • substance-occlusive poorly soluble materials that are safe for oral use include poly(dimethyl siloxane), poly(tetrafluoro ethylene), cellulose acetate, and copolymers of neutral methacrylic acid esters with one or both of methacrylic acid and diethylaminoethyl methacrylate.
  • the adhesive can be loaded with a flavoring or a mouth deodorant to act as a breath freshener, or with an antibacterial. Suitable flavorings, mouth deodorants, and antibacterials are known in the oral hygiene art. As the adhesive slowly dissolves, the agent is gradually released into the oral cavity.
  • the adhesive can be loaded with a substance to be delivered transmucosally; in this configuration, the dental prosthesis works as an occlusive backing.
  • the water-soluble pressure-sensitive adhesives of the invention can be employed as an adhesive layer in a laminated device for diffusional delivery of an agent within a mucosa-lined body cavity.
  • a laminated device for diffusional delivery of an agent within a mucosa-lined body cavity.
  • Such laminated devices can take any of a variety of forms, and may have just one layer in addition to the adhesive (such as the substance-occlusive poorly soluble layer described above, for example), or many additional layers.
  • Water-soluble pressure-sensitive adhesive films according to the invention can be made by other processes than described above. Where a press is used to form the film, for example, different temperatures may be used, according to the particular polymer composition.
  • the molten polymer may be extruded through a slit die to form a film of the desired thickness; or it can be extruded or cast as a single film between release surfaces. In the latter case, the product can be cut to a shape appropriate to the particular application, and the release liners can be peeled away just prior to use.

Abstract

Water-soluble pressure-sensitive adhesives include a water-soluble polymer that is made tacky at room temperature by addition of a water-soluble plasticizer that is miscible with the polymer. Suitable polymers are solid at room temperature and have a hydrophilicity as measured by water uptake greater than about 25 %. Suitable plasticizers are liquid at room temperature and having a boiling point higher than about 80 °C. The adhesives according to the invention may conveniently be provided in dry film form. Preferred water-soluble pressure-sensitive adhesives of the invention adhere both to mucosal surfaces and to a variety of materials that may constitute a part of a device or prosthesis to be held in a body cavity that has a mucosal lining, and adhesive films of the invention are useful as denture adhesives. For use in the oral cavity preferred adhesives of the invention are made of GRAS- or NF-certified materials.

Description

WATER-SOLUBLE PRESSURE-SENSITIVE MUCOADHESIVE
TECHNICAL FIELD This invention relates to mucoadhesives, and particularly to compositions that adhere both to mucosal surfaces and to a variety of materials that may constitute a part of a device or prosthesis to be held in a body cavity that has a mucosal lining.
BACKGROUND ART Various bioadhesives have been proposed for use in establishing adhesive contact with mucosal surfaces.
For example, U.S. Patent No. 4,713,243 describes an extruded film for use in controlled release of medicaments, including a water-soluble or swellable polymer matrix capable of adhering to a wet mucous surface, made up of 40 - 95 % hydroxy propyl cellulose, 5 - 60 % poly(ethylene oxide), optionally up to 10 % of a water-insoluble polymer (ethyl cellulose, propyl cellulose, polyethylene or polypropylene) and 2 - 10 % of a plasticizer introduced to facilitate processing, and containing the medicament. There is no disclosure in the '243 patent that such compositions can adhere to materials that may be used in oral prosthesis or other devices, or that they are pressure-sensitive. U.S. Patent No. 4,948,580 describes a bioadhesive composition for delivery of anti-bacterials, including a copolymer of ("PVME/MA"), and gelatin, dispersed in an ointment base. Adhesives for affixing dental prostheses in the mouth are conventionally in the form of pastes or creams. These are messy and inconvenient to use, and generally adhere poorly or not at all after extended periods.
U.S. Patent No. 4,529,748 describes a dental prosthesis adhesive in powder form, in which the particles are made from carboxy methyl cellulose, poly(ethylene oxide), poly(acrylic acid), and karaya gum. Some portion of the particles are coated with a cellulose or acrylate polymer film that dissolves slowly in saliva.
SUMMARY OF THE INVENTION
We have discovered water-soluble pressure-sensitive mucoadhesives that additionally adhere to a variety of materials, such as polymers, that can be used in construction of devices for emplacement on a mucosal surface or within a body cavity that has a mucosal lining. The adhesives require no moistening prior to contact with the mucosal or the polymer surface. Water-soluble pressure- sensitive mucoadhesive films according to the invention can be used, for example, to affix a dental plate within the mouth.
Or for example, water-soluble pressure sensitive films according to the invention can constitute the adhesive layer of a laminated mucoadhesive device for emplacement in a mucosa-lined body cavity and delivery of one or more active substances into the body cavity, in which additional layers or layers, also soluble in the fluids bathing the surface of the body cavity, contain the active substance or substance to be delivered. In one general aspect, the invention features a layered composite mucoadhesive device for delivery of an active substance into the oral cavity, having an active-containing layer that includes the active substance dispersed or dissolved in a water soluble polymer, and a water soluble adhesive layer.
In some embodiments the active-containing water soluble polymer layer is a hydrophobic material that will not dissolve in cold water (below about 40°C) and has little or no tendency to hydrate with water. The material may further be hot water dispersible and may have non-tacky surface properties upon moistening. Examples of suitable GRAS-certified materials include but are not limited to monoglycerides, triglycerides, waxes such as paraffin, fatty acids, fatty alcohols and mixtures thereof.
The rate of release of the active substance within the oral cavity depends to at least some extent upon the rate of dissolution or dispersion of the polymer of the active layer in situ, which in turn varies substantially according to the molecular weight of the principal polymer component: a given polymer type dissolves or disperses more slowly at higher molecular weights than at lower molecular weights. In some embodiments the active-containing layer includes a polymer such as hydroxypropyl cellulose, and may additionally include a plasticizer such as glycerin. In a particular embodiment, hydroxypropyl cellulose (HPC Klucel LF), having a molecular weight of 80,000, with glycerin as a plasticizer, is useful.
Any of a variety of active substances may be delivered using devices constructed according to the invention. Such active substances are well known to those of skill in the art to which this invention pertains. For relief of sore throat pain, for example, substance such as benzocaine, lidocaine, dyclonine and the like, which are available over the counter or in syrup or tablet form, may be used.
For relief of cough, substances such as detromethorphan IIBr, nosepine, codeine phosphate, methol, and the like may be used. Suitable odorants and flavorants include, for example, mint odorants and fruit flavorants such as citrus flavorants, cherry flavorants, and the like. Reference is made to G. Reineccius, ed. Source Book of Flavors, Chapman & Hall.
For placement within the oral cavity, for example, the adhesive preferably is made from materials generally regarded as safe ("GRAS-certified"), or national formulary ("NF-certified"), and therefore safe for oral use or for ingestion.
The pressure-sensitive adhesives of the invention are fully water-soluble, and are thus fully soluble in secretions present in mucous-lined body cavities. Consequently, the adhesive eventually dissolves completely within the body cavity in which they are placed, and is flushed away with the fluid secretions of the cavity or, in the case of use in the oral cavity, passes on to the alimentary canal.
DISCLOSURE OF THE INVENTION
Accordingly, in one general aspect, the invention features a water-soluble pressure-sensitive adhesive including a water-soluble polymer that is made tacky (that is, it is rendered pressure-sensitive) at room temperature by addition of a water-soluble plasticizer that is miscible with the polymer. Suitable polymers are characterized as being solid at room temperature (that is, as having a glass transition temperature T(g), or melting point T(m), higher than about 25°C, and more preferably higher than about 30°C, and lower than about 120°C, and more preferably lower than about 100°C); and having a hydrophilicity as measured by water uptake greater than about 25 %. Suitable plasticizers are characterized as being liquid at room temperature and having a boiling point higher than about 80°C.
Suitable polymers include polysaccharides such as for example cellulose- type materials and natural gums, polypeptides, and water-soluble synthetic polymers. Particular examples of such suitable polymers which are GRAS certified include poly(vinyl pyrrolidone) ("PVP"), poly(vinyl alcohol) ("PVA"), hydroxy propyl cellulose ("HPC"), polyethylene oxide) ("PEO"), poly(acrylic acid) ("PAA"), polyacrylates such as Carbopol 934 (B.F. Goodrich), starch and starch derivatives, polysaccharides, sodium carboxymethyl cellulose
("Na-CMC"), xanthan gum, karaya gum, and gelatin, among others. Suitable plasticizers include, for example and particularly for oral-mucosal contact and other use in the oral cavity, glycerin, sorbitol, any of the glycols, polysorbate 80, triethyl citrate, acetyl triethyl citrate, and tributyl citrate. In some embodiments for oral mucosal contact and for skin contact, a water-soluble pressure-sensitive adhesive according to the invention includes PVP (about 95 - 40 weight %) and, optionally, HPC (up to about 50 weight %) as a polymer; and glycerin as a plasticizer (about 5 - 35 weight %). Optionally, any balance (up to about 30 weight %) can be made up by water. By way of illustration, such compositions adhere instantaneously (within less than five seconds) to oral mucosal surfaces and to oral cavity prostheses or other devices of the poly(methyl methacrylate) ("PMMA") type, as well as to human skin.
In other embodiments for oral mucosal contact and for skin contact, a water-soluble pressure-sensitive adhesive according to the invention includes as a polymer HPC (about 0 - 50 weight %) and, optionally, (up to about 50 weight %) one or more of PVP, PVA, PEO, starch, polysucrose or other polysaccharide, xanthan gum, or karaya gum; and glycerin as a plasticizer (about 1 1 - 60 weight % and, preferably about 30 - 50 weight % for PVP- or HPC-containing adhesive compositions). In these formulations, the HPC preferably has a molecular weight between about 60 k and about 1 ,000 k, and more preferably between about 100 k and about 300 k.
In another general aspect, the invention features a water-soluble pressure- sensitive adhesive film made up of a water-soluble polymer that is made tacky (that is, it is rendered pressure-sensitive) at room temperature by addition of a water-soluble plasticizer that is miscible with the polymer.
In preferred embodiments the thickness of the film is in the range of about 5 - 20 mils, and is shaped to fit and to conform generally to a mucosal surface- contacting portion of a dental prosthesis such as a dental plate. Preferred water- soluble pressure-sensitive adhesive films according to the invention are very flexible, and are therefore capable of conforming to and adhering to contoured surfaces such as the gum or the roof of the mouth. Such a film can be used as a denture adhesive, that can adhere to oral mucosal surfaces and to dental prosthesis for an extended period, typically of more than about 5 hours. The film can be used as part of a system for delivery of substances through the oral mucosa (as a buccal transmucosal patch), or for delivery of substances into the oral cavity itself. In another general aspect, the invention features a laminated mucoadhesive device for emplacement on a mucosal surface, such as on a surface within a body cavity that has a mucosal lining, which device has a first layer made up of a water-soluble pressure-sensitive adhesive as described herein and a second water- soluble layer containing the active substance. As the active substance-containing layer dissolves or otherwise disperses within the fluids bathing the surface of the body cavity, the active substance is released into and is carried by the fluids. In some embodiments the laminated device includes two or more water soluble active substance-containing layers. Each of the layers may contain a different active substance or combination of active substances, for example; or they may contain the same active substance but in differing amounts. The different active substance-containing layers may dissolve or disperse at different rates in the fluids of the body cavity, so that the rate of release of the active substance or active substances may vary over time.
In preferred embodiments the active substance includes a flavorant or deodorant or reordorant and is useful in the body cavity as a deodorant or odor masking agent, for example as a breath freshener in the oral cavity; or it includes an antibacterial or antifungal agent, useful in the body cavity to treat enfection or to prevent formation of odor; or it includes an anaesthetic or analgesis, useful in the body cavity to treat pain.
Description of Preferred Embodiments
BEST MODE FOR CAR YING OI JT THE INVENTION Modes of Carrying out the invention
1. Preparation of a water-soluble pressure-sensitive adhesive composition made up of PVP and glycerin. 0
A solution of poly( vinyl pyrrolidone) ("PVP": Kollidon®, obtained from BASF) and glycerin was first prepared in isopropyl alcohol ("IPA"), in the following proportion by weight: 15 parts PVP, 6 parts glycerin, and 79 parts IPA. The solution was coated on a polyester release liner and allowed to dry at room temperature for 15 hours to permit evaporation of the IPA. The resulting dry film is both pressure-sensitive and water-soluble.
Measurements of tack were made using a TA.XT2 Texture Analyzer (Texture Technologies Corp.) together with an XT.RA Dimension software package (Stable Micro Systems, Ltd.), as follows. A sample of the film on a release liner is mounted upon a block, and a probe is moved at a fixed speed against the adhesive surface of the film, distorting the film to a fixed penetration depth, where the probe is permitted to dwell for a fixed time. The probe is then withdrawn from the film, at a fixed speed, and the peak force required to detach the probe from the film surface is measured as a measure of tack. Measured tack of samples of a PVP-glycerin film prepared as described above and having 5 mils thickness was 1820 g/cm2, using a probe diameter of 0.80 cm, a penetration depth of 0J mm, a penetration rate of 1.0 mm/sec, a dwell time of 10 sec, and a withdrawal rate of 5.0 mm/sec. Typical tack values for adhesives used in transdermal devices, for example, are about 1000 - 2000 g/cm . Measurements of water solubility were made by submersion of a sample of the film in water at 21°C, stirring the water, and determining the time required for apparent complete dissolution of the film.
The total measured dissolution time of samples of a PVP-glycerin film prepared as described above and having 5 mils thickness was about 10 minutes.
2. Preparation of a water-soluble pressure-sensitive adhesive composition made up of HPC, PVP and glycerin.
Hydroxy propyl cellulose ("HPC"), PVP and glycerin were first blended in the proportion, by weight, of 4 parts HPC, 2 parts PVP, and 2 parts glycerin. The resulting mixture was pressed in a heated Carver laboratory press at 200 OF to a 0
thickness about 35 mils. The resulting film was flexible, translucent and tacky at room temperature.
3. Preparation of dental prosthesis adhesive film. A water-soluble pressure-sensitive adhesive film made as described above can be die-cut in a shape that conforms to that portion of the dental prosthesis that closely fits the mucosal surface of the mouth, such as the part of the dental plate that fits against the palate. The shaped film pieces can be packaged dry. For use, the dry film is pressed onto the appropriate surface of the dental prosthesis so that it adheres. Then the dental prosthesis with the adhesive affixed is inserted into the correct position in the mouth and pressed against the mucosal surface until adhesion is achieved.
The following Examples are intended to illustrate but not to limit the invention.
EXAMPLES Example I
Breath Freshening Device A dissolvable mucoadhesive device capable of releasing a flavor into the oral cavity was constructed as follows: A solution was made up by co-dissolving 15.4 grams of polyvinyl pyrrolidone PVP (K90) and 6.0 grams of glycerin in 80 grams of isopropanol (IPA). The resulting solution was coated at a thickness of 30 mils onto a polyester release liner and allowed to dry for 15 hours at room temperature. The resulting dry film was tacky at room temperature and had a final thickness of about 5 mils. A second solution containing 43 grams of IPA, 42 grams of water, 15 grams of HPC EF, 2.5 grams of peppermint oil and 3.0 grams of NutrasweetO brand sweetener containing aspartame was prepared by mixing all the components until fully dissolved. The solution was then coated at a thickness of 50 mils onto a polyester release liner. The film was allowed to dry at room temperature for 15 hours to a final thickness of about 5 mils.
The two dry films were laminated together. Discs having a diameter of about 1.2 cm were cut from the laminate. The discs were tested in vivo by adhering a single disc to the upper palate of three volunteers. The discs adhered well to the mucosal surface and upon hydration with saliva immediately began releasing peppermint oil and aspartame as noticed by taste. The total time of dissolution in the mouth was about 10 minutes, during which time a pleasant, refreshing mint flavor was perceived.
Example II
Adhesive Layer Optimized for High Tack and long Dissolution Time.
In this example, adhesive layer compositions having various selected proportions of PVP, HPC, and Glycerol were tested both for peak tack and for time required to complete dissolution, in order to determine both the relative contribution each of these components makes to the tack and dissolution time characteristics of the adhesive, and to determine the ranges within which the proportions of these components preferable are provided, to provide adhesives having good tack and dissolution time characteristics.
The adhesive layers were constructed by blending HPC, PVP and Glycerin in the selected proportion, and pressing the resulting mixture in a heated Carver laboratory press at 200 F. to a thickness about 35 mils.
Peak tack was tested on adhesive disks having 10 mils thickness, using a TA.XT2 Texture Analyzer, with a Plexiglas probe having a diameter 8mm, advanced to the surface at 1 mm/sec to a force threshold of 20 grams, then advanced at a penetration rate of 0J mm/sec to a penetration depth of 0.5 mm, held for 10 seconds at a contact force of 125 grams, and then withdrawn at 1 mm/sec. Time to complete dissolution was measured by affixing an adhesive disc to the inner wall of a vial containing 100 ml nanopure water at room temperature and stirring the water at 250 rpm.
The results are shown in Table I.
TABLE I
Reference HPC PVP Gly Tack Diss.Time
(%) (%) (%) (g) (min)
319-099 20 38 42 403±62 28.3±2.6
319-100 33 32 35 478±41 53.2±10.5
319-101 13 52 35 749±112 26.2±6J
319-102 13 32 55 516±64 31.8±4.2
319-103 20 38 42 410±67 32J±6.3
319-104 33 32 35 425±32 50.2±7.4
310-105 13 52 35 815+161 22.2±2.6
310-129 20 30 50 527±46 56.7±4.0
310-130 10 45 45 572±64 25.0±6.4
310-131 30 30 40 526±101 58.6±4.0
310-132 20 45 35 405±59 38.9±13.0
298-85 33 30 37 388±70 64.7±20.6
298-86 33 25 42 585±88 77.0±11J
310-108-2 16 47 37 584±117 39.4±18.4
310-120-2 16 44 40 492±143 27.0±9.07
310-124-2 16 41 43 511±102 24.6±5.3
In a first step, samples appearing in Table I as Reference Nos. 310- 108-2, 310-120-2, and 310-124-2 were formulated and tested. The data for tack and dissolution time for these samples were then analyzed and the resulting analysis was used to select compositions for additional formulation and testing. The selected compositions appear in Table I as Reference Nos. 310- 129, 310-130, 310-131, and 310-132, and Reference Nos. 319-099, 319-100, 319- 101, 319-102, 319-103, 319-104, and 319-105.
The data for tack and dissolution time for these selected compositions were then further analyzed to provide ranges for optimization, and two such optimized compositions were selected and tested. These are numbered 298-85 and 298-86 in Table I. The results were analyzed to rank the variables according to their effect on the tack and dissolution characteristics. The concentration ranges (weight %) that were considered were HPC: 13%-43%; PVP: 32%-52%; Glycerine: 35%-55%.
Taken alone within broad limits, varying PVP had much the greatest effect on tack, followed by HPC; varying Glycerin within broad limits had relatively little effect on tact. Tack was apparently highly affected by variations in HPC and
PVP together, and less by variations in PVP and Glycerin together.
Taken alone and within broad limits, varying either HPC or PVP had a significant effect on dissolution time; varying Glycerin within broad limits had relatively little effect on dissolution time. Generally, for broad range in Glycerin and HPC contents, dissolution time increases at PVP concentrations less than about 34% by weight. Also generally, for a broad range of HPC (particularly above about 20%, more particularly above about 30%, by weight) and Glycerin contents, tack increases at PVP concentration either less than about 35% by weight or greater than about 44% by weight. On this analysis, therefore, optimized tack and dissolution times are expected for compositions having less than about 34% by weight PVP, and above about 20% (more preferable above about 30%) by weight HPC. Example III
Device for Relief of Sore Throat Pain
A medication-containing mucoadhesive laminated disc according to the invention can be made by forming and then laminating an adhesive film and an active substance-containing polymer film generally as follows.
The adhesive layer. A water-soluble adhesive layer can be formed from an adhesive polymer film, according to the following general protocol. First, the polymer (or polymers) and the plasticizer are thoroughly mixed, using where necessary a suitable solvent such as ethyl alcohol. Where a solvent is used, the resulting mixture is then coated on a release liner, and the solvent is allowed to evaporate to produce a dry film. Dry film samples are then collected and pressed to the desired final film thickness. Where no solvent is used, the mixture can be pressed to a film of the desired thickness.
The active substance-containing layer. First, the polymers and one or more desired active agents and one or more desired flavorants are dissolved, for example by stirring, in an appropriate solvent. Then the resulting thickened solution is formed into a thin (wet) film, for example by casting onto a release liner, and then the solvent is permitted to evaporate to a dry film. Then the dry film is pressed to a desired thickness and is affixed, for example by pressing, onto an adhesive layer prepared as described above.
Hydroxypropyl cellulose (HPC) can be a particularly suitable polymer for construction of the active-containing layer. HPC dissolves completely in aqueous fluids such as the fluids of the oral cavity, and within a selected range of molecular weights, HPC dissolves (or disperses) in the oral cavity sufficiently slowly to provide substantially continuous delivery of the active substance over an extended period. HPC is flexible, so that it conforms well to irregular curved surfaces of the oral cavity; HPC is not tacky when moistened, and has a pleasant texture in the mouth. It is thus comfortable and unobtrusive for the user. HPC blends well with a variety of active substances.
Glycerol, which may be added as a plasticizer in the active-containing layer, may additionally (or alternatively) act to inhibit crystallization of some active substances that might otherwise occur at the loading concentrations employed (for example, menthol).
Laminated devices are then cut from the laminated film by, for example, die-cutting, to the desired size and shape. Typically, circular or oval shapes may be preferred. The devices can be stored on a release liner affixed to the adhesive surface, and removed from the liner as needed by the user.
A device having a single active substance-containing layer containing a pain-relieving agent such as dyclonine A in amounts sufficient to provide sore throat pain relief initially can have the undesired effect of unpleasantly numbing other tissues in the oral cavity that are adjacent the device while in place, such as the tongue. We have discovered that delivery of the active in two phases can * reduce this undesired effect while providing sustained relief from pain.
A preferred device for two-phase delivery of an active substance for relief of sore throat has two active-containing layers, a first layer adjacent the adhesive layer, from which the active is released more slowly over time, and a second layer adjacent the first active-containing layer, from which the active is released more rapidly, over a shorter initial time following placement within the body cavity. Such a configuration provides for an initial burst of the pair-relieving active agent at a suitably high rate to satisfactorily reduce sore throat pain, followed by a sustained release of the active agent at a lower rate suitably high to maintain the effect of pain reduction but not so high as to cause unpleasant numbness in the oral cavity. Accordingly, this invention also provides a method of delivery an active substance to a subject such as a human patient by contacting a device as described herein with a suitable surface of the subject. Suitable surfaces include, but are not limited to a mucosa-lined body cavity such as the oral cavity, the cornea stratum or the skin of the subject. The two-phase release profile can be achieved either by having the two active-containing layers made from the same polymer (or from similar polymers dissolving or dispersing at about the same rate) but having the active agent present in the lower, sustained release layer at a lower concentration than in the upper, initial burst, layer. Or, the upper layer can dissolve or disperse more quickly in the oral milieu.
In one example for a two-phase delivery of dyclonine, the device is about 0.5 inches in diameter, the layers are made from the same HPC polymer, and the initial release layer can be 5-10 mils thick, and contain 0.25-0.6 milligrams of dyclonine, while the sustained release layer can be 20-25 mils thick, and contain
1-1.5 milligrams of dyclonine. Such a configuration can provide satisfactory throat pain relief within about 1—20 minutes' time, followed by a sustained relief over a time greater than an hour thereafter, while reducing the numbing effect associated with delivery at a constant higher rate.
Other Embodiments For example, the water-soluble pressure-sensitive adhesives according to the invention can be used to affix transdermal devices to human skin. Because the materials in the adhesive are GRAS certified, they can result in an adhesive product having very low skin irritation and reaction.
The water-soluble pressure-sensitive adhesives of the invention can act as a reservoir for diffusional delivery of a substance into the mucosa-lined body cavity (such as the oral cavity or gastrointestinal tract, or the vaginal cavity), or for delivery of a substance transmucosally through the area of adhesive contact. Preferably for such applications, the adhesive is provided in film form, and is loaded with a suitable quantity of the substance to be delivered. For use in transmucosal delivery, one surface of the adhesive film makes adhesive contact with the mucosal surface; preferably the other surface of the adhesive film is covered with a substance-occlusive backing layer made of a material that is poorly soluble in water or in the fluid secretions of the body cavity in which the film is used. Examples of substance-occlusive poorly soluble materials that are safe for oral use include poly(dimethyl siloxane), poly(tetrafluoro ethylene), cellulose acetate, and copolymers of neutral methacrylic acid esters with one or both of methacrylic acid and diethylaminoethyl methacrylate. In a dental prosthesis adhesive film application, for example, the adhesive can be loaded with a flavoring or a mouth deodorant to act as a breath freshener, or with an antibacterial. Suitable flavorings, mouth deodorants, and antibacterials are known in the oral hygiene art. As the adhesive slowly dissolves, the agent is gradually released into the oral cavity. Or, in a dental prosthesis adhesive film application, the adhesive can be loaded with a substance to be delivered transmucosally; in this configuration, the dental prosthesis works as an occlusive backing.
The water-soluble pressure-sensitive adhesives of the invention can be employed as an adhesive layer in a laminated device for diffusional delivery of an agent within a mucosa-lined body cavity. Such laminated devices can take any of a variety of forms, and may have just one layer in addition to the adhesive (such as the substance-occlusive poorly soluble layer described above, for example), or many additional layers.
Water-soluble pressure-sensitive adhesive films according to the invention can be made by other processes than described above. Where a press is used to form the film, for example, different temperatures may be used, according to the particular polymer composition.
For example, the molten polymer may be extruded through a slit die to form a film of the desired thickness; or it can be extruded or cast as a single film between release surfaces. In the latter case, the product can be cut to a shape appropriate to the particular application, and the release liners can be peeled away just prior to use.
It is to be understood that while the invention has been described in conjunction with the above embodiments, that the foregoing description and examples are intended to illustrate and not limit the scope of the invention. Other aspects, advantages and modifications within the scope of the invention will be apparent to those skilled in the art to which the invention pertains.

Claims

1. A water-soluble pressure-sensitive adhesive comprising a water- soluble polymer and a water-soluble plasticizer, said polymer having a T(g) or a T(m) greater than about 25°C and having a hydrophilicity greater than about
25 %, said plasticizer being miscible with said polymer at room temperature and being liquid at room temperature and having a boiling point higher than 80 °C.
2. The water-soluble pressure sensitive adhesive of claim 1 wherein said polymer has a T(g) or a T(m) greater than about 30°C.
3. The water-soluble pressure-sensitive adhesive of claim 1, said polymer comprising poly(vinyl pyrrolidone) and said plasticizer comprising glycerol.
4. The water-soluble pressure-sensitive adhesive of claim 3, said polymer further comprising hydroxy propyl cellulose.
5. The water-soluble pressure-sensitive adhesive of claim 3, comprising 95 - 40 weight % poly(vinyl pyrrolidone), 0 - 50 weight % hydroxy propyl cellulose, and 1 1 - 60 weight % glycerol.
6. The water-soluble pressure-sensitive adhesive of claim 3 further comprising hydroxy propyl cellulose.
7. The water-soluble pressure-sensitive adhesive of claim 3 wherein said poly( vinyl pyrrolidone) comprises less than about 34% by weight of said composition.
8. The water-soluble pressure-sensitive adhesive of claim 3 wherein said hydroxy propyl cellulose comprises about 20% - 50% by weight of said composition.
9. The water-soluble pressure-sensitive adhesive of claim 5, said glycerol being present in the range 30 - 50 weight %.
10. The water-soluble pressure-sensitive adhesive of claim 1, in film form.
1 1. A dental prosthesis adhesive, comprising the water-soluble pressure-sensitive adhesive film of claim 7, shaped to conform to a protion of the mucosal surface-contacting surface of the dental prosthesis.
12. A device for two-phase delivery of an active substance, comprising: a) a first layer containing an effective amount of the active substance; b) a second layer containing the active substance; and c) an adhesive layer, wherein the first layer is positioned adjacent the adhesive layer, from which the active substance is released more slowly over wear time of the device as compared to the release rate of the second layer, and the second layer adjacent the first active-containing layer, from which the active is released more rapidly over a shorter initial wear time of the device as compared to the release rate of the first layer.
13. A method of delivering for the two-phase delivery of an active substance, the method comprising contacting the device of claim 12 with a surface of a subject.
PCT/US1996/002666 1995-02-23 1996-02-23 Water-soluble pressure-sensitive mucoadhesive WO1996025910A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU52999/96A AU5299996A (en) 1995-02-23 1996-02-23 Water-soluble pressure-sensitive mucoadhesive

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US39347095A 1995-02-23 1995-02-23
US08/393,470 1995-02-23
US58905996A 1996-01-19 1996-01-19
US08/589,059 1996-01-19

Publications (1)

Publication Number Publication Date
WO1996025910A1 true WO1996025910A1 (en) 1996-08-29

Family

ID=27014301

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1996/002666 WO1996025910A1 (en) 1995-02-23 1996-02-23 Water-soluble pressure-sensitive mucoadhesive

Country Status (2)

Country Link
AU (1) AU5299996A (en)
WO (1) WO1996025910A1 (en)

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6551579B2 (en) * 1997-06-06 2003-04-22 The Procter & Gamble Company Delivery systems for a tooth whitener
EP1362584A1 (en) * 1996-11-11 2003-11-19 LTS Lohmann Therapie-Systeme AG Immediate wettability water soluble film or water soluble layer for oral application
DE10302424B4 (en) * 2002-01-25 2005-04-28 Pms Handelskontor Gmbh Adhesive for a denture
EP1676559A2 (en) * 2005-01-03 2006-07-05 L'oreal Cosmetic or dermatological article containing a support which is soluble in water
WO2007056606A1 (en) * 2005-11-09 2007-05-18 The Procter & Gamble Company Denture adhesive articles
US7834066B2 (en) 2005-11-09 2010-11-16 The Procter & Gamble Company Denture adhesive articles
RU2448678C2 (en) * 2005-11-09 2012-04-27 Дзе Проктер Энд Гэмбл Компани Dental adhesion compositions
US8735465B2 (en) 2010-03-10 2014-05-27 The Procter & Gamble Company Denture adhesive compositions
US9554976B2 (en) 2002-09-11 2017-01-31 The Procter & Gamble Company Tooth whitening product
US10285916B2 (en) 2012-10-17 2019-05-14 The Procter & Gamble Company Strip for the delivery of an oral care active and methods for applying oral care actives
US11931227B2 (en) 2013-03-15 2024-03-19 Cook Medical Technologies Llc Bimodal treatment methods and compositions for gastrointestinal lesions with active bleeding

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4373036A (en) * 1981-12-21 1983-02-08 Block Drug Company, Inc. Denture fixative composition
US4713243A (en) * 1986-06-16 1987-12-15 Johnson & Johnson Products, Inc. Bioadhesive extruded film for intra-oral drug delivery and process
JPS63171565A (en) * 1987-01-07 1988-07-15 積水化学工業株式会社 Constitutional body for adhesion of mucous membrane of oral cavity and its production
JPS63174660A (en) * 1987-01-14 1988-07-19 積水化学工業株式会社 Adhesive composition for being adhered to viscous membrane of oral cavity
US5186938A (en) * 1984-07-24 1993-02-16 Key Pharmaceuticals, Inc. Adhesive transdermal dosage layer
US5271940A (en) * 1989-09-14 1993-12-21 Cygnus Therapeutic Systems Transdermal delivery device having delayed onset
US5455043A (en) * 1990-06-13 1995-10-03 Fischel-Ghodsian; Fariba Device for controlled release of vaporous medications through nasal route

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4373036A (en) * 1981-12-21 1983-02-08 Block Drug Company, Inc. Denture fixative composition
US5186938A (en) * 1984-07-24 1993-02-16 Key Pharmaceuticals, Inc. Adhesive transdermal dosage layer
US4713243A (en) * 1986-06-16 1987-12-15 Johnson & Johnson Products, Inc. Bioadhesive extruded film for intra-oral drug delivery and process
JPS63171565A (en) * 1987-01-07 1988-07-15 積水化学工業株式会社 Constitutional body for adhesion of mucous membrane of oral cavity and its production
JPS63174660A (en) * 1987-01-14 1988-07-19 積水化学工業株式会社 Adhesive composition for being adhered to viscous membrane of oral cavity
US5271940A (en) * 1989-09-14 1993-12-21 Cygnus Therapeutic Systems Transdermal delivery device having delayed onset
US5455043A (en) * 1990-06-13 1995-10-03 Fischel-Ghodsian; Fariba Device for controlled release of vaporous medications through nasal route

Cited By (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1362584A1 (en) * 1996-11-11 2003-11-19 LTS Lohmann Therapie-Systeme AG Immediate wettability water soluble film or water soluble layer for oral application
US6551579B2 (en) * 1997-06-06 2003-04-22 The Procter & Gamble Company Delivery systems for a tooth whitener
DE10302424B4 (en) * 2002-01-25 2005-04-28 Pms Handelskontor Gmbh Adhesive for a denture
US10493016B2 (en) 2002-09-11 2019-12-03 The Procter & Gamble Company Tooth whitening product
US9554976B2 (en) 2002-09-11 2017-01-31 The Procter & Gamble Company Tooth whitening product
EP1676559A2 (en) * 2005-01-03 2006-07-05 L'oreal Cosmetic or dermatological article containing a support which is soluble in water
FR2880262A1 (en) * 2005-01-03 2006-07-07 Oreal COSMETIC OR DERMATOLOGICAL ARTICLE COMPRISING A WATER-SOLUBLE SUPPORT
EP1676559A3 (en) * 2005-01-03 2006-09-13 L'oreal Cosmetic or dermatological article containing a support which is soluble in water
WO2007056612A3 (en) * 2005-11-09 2007-08-30 Procter & Gamble Denture adhesive articles
EP2295024A3 (en) * 2005-11-09 2011-09-14 The Procter & Gamble Company Denture adhesive compositions
WO2007056612A2 (en) * 2005-11-09 2007-05-18 The Procter & Gamble Company Denture adhesive articles
WO2007056609A1 (en) * 2005-11-09 2007-05-18 The Procter & Gamble Company Denture adhesive articles
WO2007056608A1 (en) * 2005-11-09 2007-05-18 The Procter & Gamble Company Denture adhesive compositions
WO2007056607A3 (en) * 2005-11-09 2008-04-17 Procter & Gamble Denture adhesive article packaging
US7834066B2 (en) 2005-11-09 2010-11-16 The Procter & Gamble Company Denture adhesive articles
WO2007056611A1 (en) * 2005-11-09 2007-05-18 The Procter & Gamble Company Denture adhesive articles
RU2448678C2 (en) * 2005-11-09 2012-04-27 Дзе Проктер Энд Гэмбл Компани Dental adhesion compositions
WO2007056606A1 (en) * 2005-11-09 2007-05-18 The Procter & Gamble Company Denture adhesive articles
WO2007056605A1 (en) * 2005-11-09 2007-05-18 The Procter & Gamble Company Denture adhesive articles
US9463145B2 (en) 2010-03-10 2016-10-11 The Procter & Gamble Company Denture adhesive compositions
US8735465B2 (en) 2010-03-10 2014-05-27 The Procter & Gamble Company Denture adhesive compositions
US10285916B2 (en) 2012-10-17 2019-05-14 The Procter & Gamble Company Strip for the delivery of an oral care active and methods for applying oral care actives
US10285915B2 (en) 2012-10-17 2019-05-14 The Procter & Gamble Company Strip for the delivery of an oral care active and methods for applying oral care actives
US11931227B2 (en) 2013-03-15 2024-03-19 Cook Medical Technologies Llc Bimodal treatment methods and compositions for gastrointestinal lesions with active bleeding

Also Published As

Publication number Publication date
AU5299996A (en) 1996-09-11

Similar Documents

Publication Publication Date Title
CA2169729C (en) Water-soluble pressure-sensitive mucoadhesive
US5750134A (en) Bioadhesive composition and patch
JP4619894B2 (en) Drug carrier device suitable for delivery of drug compounds to mucosal surfaces
US5750136A (en) Bioadhesive composition and patch
US4876092A (en) Sheet-shaped adhesive preparation applicable to oral cavity
US5780045A (en) Transmucosal drug delivery device
US5047244A (en) Mucoadhesive carrier for delivery of therapeutical agent
CA1297408C (en) Bioadhesive extruded film for intra-oral drug delivery and process
AU776525B2 (en) Compositions and methods for mucosal delivery
JP2007211030A (en) Pharmaceutical gel preparation applicable to mucosal surface and body tissue
KR0186037B1 (en) Bioadhesive Compositions and Patches
WO1996025910A1 (en) Water-soluble pressure-sensitive mucoadhesive
EP2027852A1 (en) Adhesive compositions for the treatment of xerostoma
JP2541573B2 (en) Sustained-release oral preparation
ZA200702235B (en) Self-adhesive dental floss
CN101304723B (en) Denture adhesive compositions
JP2019122702A (en) Oral cavity mucosa protective film
KR0170574B1 (en) Oral mucoadhesive patch
JP2003519641A (en) Topical medicinal bioadhesive composition, and methods of use and preparation thereof
JPS62255417A (en) Pharmaceutical preparation for oral cavity
JPS62255416A (en) Pharmaceutical preparation for oral cavity
JPS6368523A (en) Plaster preparation for external use
WO1997011688A1 (en) Use of a vinyl acetate/n-vinyl-2-pyrrolidone copolymer in a transdermal matrix system
JPH10179614A (en) Denture stabilizer
JPH0368672A (en) Self-adhesive tape

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AL AM AT AU AZ BB BG BR BY CA CH CN CZ DE DK EE ES FI GB GE HU IS JP KE KG KP KR KZ LK LR LS LT LU LV MD MG MK MN MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TT UA US UZ VN

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
122 Ep: pct application non-entry in european phase